Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Red light therapy may help prevent memory loss as we age.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Co-trimoxazole may help treat autoimmune diseases.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

PRP, exosomes, and physical therapies show promise for hair and tissue repair, but need more research for optimization.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Transdermal delivery systems show promise for treating hair loss by delivering drugs directly through the skin.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.